Skip to main content
Kent Academic Repository

Identification of key clinical phenotypes of breast cancer using a reduced panel of protein biomarkers

Green, A.R., Powe, D.G., Rakha, E.A., Soria, D., Lemetre, C., Nolan, C.C., Barros, F.F.T., Macmillan, R.D., Garibaldi, J.M., Ball, G.R., and others. (2013) Identification of key clinical phenotypes of breast cancer using a reduced panel of protein biomarkers. British Journal of Cancer, 109 (7). pp. 1886-1894. ISSN 0007-0920. E-ISSN 1532-1827. (doi:10.1038/bjc.2013.528) (KAR id:98892)

Abstract

Background:Breast cancer is a heterogeneous disease characterised by complex molecular alterations underlying the varied behaviour and response to therapy. However, translation of cancer genetic profiling for use in routine clinical practice remains elusive or prohibitively expensive. As an alternative, immunohistochemical analysis applied to routinely processed tissue samples could be used to identify distinct biological classes of breast cancer.Methods:In this study, 1073 archival breast tumours previously assessed for 25 key breast cancer biomarkers using immunohistochemistry and classified using clustering algorithms were further refined using naïve Bayes classification performance. Criteria for class membership were defined using the expression of a reduced panel of 10 proteins able to identify key molecular classes. We examined the association between these breast cancer classes with clinicopathological factors and patient outcome.Results:We confirm patient classification similar to established genotypic biological classes of breast cancer in addition to novel sub-divisions of luminal and basal tumours. Correlations between classes and clinicopathological parameters were in line with expectations and showed highly significant association with patient outcome. Furthermore, our novel biological class stratification provides additional prognostic information to the Nottingham Prognostic Index.Conclusion:This study confirms that distinct molecular phenotypes of breast cancer can be identified using robust and routinely available techniques and both the luminal and basal breast cancer phenotypes are heterogeneous and contain distinct subgroups. © 2013 Cancer Research UK.

Item Type: Article
DOI/Identification number: 10.1038/bjc.2013.528
Uncontrolled keywords: breast cancer classification, immunohistochemistry, stratification, Tumour biomarkers
Subjects: Q Science
Divisions: Divisions > Division of Computing, Engineering and Mathematical Sciences > School of Computing
Funders: University of Nottingham (https://ror.org/01ee9ar58)
Depositing User: Daniel Soria
Date Deposited: 08 Dec 2022 10:01 UTC
Last Modified: 05 Nov 2024 13:04 UTC
Resource URI: https://kar.kent.ac.uk/id/eprint/98892 (The current URI for this page, for reference purposes)

University of Kent Author Information

  • Depositors only (login required):

Total unique views for this document in KAR since July 2020. For more details click on the image.